Symbols

How did SLN's earnings per share perform in Q3 2023?

4/3/2025 09:14am

Aime

Silence Therapeutics (SLN) reported a negative diluted EPS of $0.09 for Q3 2023, reflecting a loss for the period¹.

SLN Diluted EPS YoY, Diluted EPS

Source:

1. SLN EPS in Q3 2023